Teachers Retirement System of The State of Kentucky bought a new position in Cantel Medical Corp. (NYSE:CMD) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 13,000 shares of the company’s stock, valued at approximately $1,013,000.
Several other large investors have also added to or reduced their stakes in CMD. BlackRock Inc. purchased a new stake in Cantel Medical Corp. during the 2nd quarter valued at about $376,271,000. Vanguard Group Inc. purchased a new stake in Cantel Medical Corp. during the 2nd quarter valued at about $246,860,000. Neuberger Berman Group LLC purchased a new stake in Cantel Medical Corp. during the 2nd quarter valued at about $96,236,000. Wells Fargo & Company MN purchased a new stake in Cantel Medical Corp. during the 2nd quarter valued at about $75,715,000. Finally, New York State Common Retirement Fund purchased a new stake in Cantel Medical Corp. during the 2nd quarter valued at about $71,128,000. 83.79% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Teachers Retirement System of The State of Kentucky Buys Shares of 13,000 Cantel Medical Corp. (CMD)” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://sportsperspectives.com/2017/10/11/teachers-retirement-system-of-the-state-of-kentucky-buys-shares-of-13000-cantel-medical-corp-cmd.html.
In other Cantel Medical Corp. news, Director Mark N. Diker sold 7,000 shares of the business’s stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total value of $692,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Charles M. Diker sold 20,500 shares of the business’s stock in a transaction dated Wednesday, October 4th. The stock was sold at an average price of $99.15, for a total transaction of $2,032,575.00. The disclosure for this sale can be found here. Insiders own 14.90% of the company’s stock.
Shares of Cantel Medical Corp. (NYSE:CMD) opened at 94.97 on Wednesday. Cantel Medical Corp. has a 12 month low of $68.19 and a 12 month high of $99.83. The company’s 50-day moving average is $86.01 and its 200 day moving average is $78.13. The stock has a market capitalization of $3.94 billion, a P/E ratio of 55.54 and a beta of 1.25.
Cantel Medical Corp. (NYSE:CMD) last announced its earnings results on Thursday, September 28th. The company reported $0.54 EPS for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.02. The business had revenue of $205.50 million during the quarter, compared to the consensus estimate of $200.32 million. Cantel Medical Corp. had a net margin of 9.27% and a return on equity of 17.60%. The firm’s quarterly revenue was up 14.8% compared to the same quarter last year. Equities research analysts predict that Cantel Medical Corp. will post $2.34 earnings per share for the current year.
Several brokerages recently commented on CMD. Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical Corp. in a research report on Friday, September 1st. Zacks Investment Research downgraded shares of Cantel Medical Corp. from a “buy” rating to a “sell” rating in a research report on Wednesday, August 2nd. Finally, Sidoti raised shares of Cantel Medical Corp. from a “neutral” rating to a “buy” rating and set a $92.00 price objective on the stock in a research report on Wednesday, August 2nd. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $91.67.
Cantel Medical Corp. Profile
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.